Accès à distance ? S'identifier sur le proxy UCLouvain
FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies.
Primary tabs
| Document type | Article de périodique (Journal article) – Lettre à l'éditeur |
|---|---|
| Access type | Accès restreint |
| Publication date | 2016 |
| Language | Anglais |
| Journal information | "Haemophilia" - Vol. 22, no.1, p. e36-e38 (2016) |
| Peer reviewed | yes |
| Publisher | Wiley-Blackwell Publishing Ltd. ((United Kingdom) Oxford) |
| issn | 1351-8216 |
| e-issn | 1365-2516 |
| Publication status | Publié |
| Affiliations |
UCL
- SSS/IREC/CARD - Pôle de recherche cardiovasculaire UCL - (SLuc) Service d'hématologie |
| MESH Subject | Databases, Pharmaceutical ; Drug Discovery ; Factor VIII ; Hemophilia A ; Humans ; Registries ; Safety |
| Links |
| Bibliographic reference | Fischer, Kathelijn ; Iorio, Anna ; Hollingsworth, Robert ; Makris, Mike ; EUHASS collaborators ; et. al. FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies.. In: Haemophilia, Vol. 22, no.1, p. e36-e38 (2016) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/184493 |